Citadel Advisors
KRMD icon

Citadel Advisors’s KORU Medical Systems KRMD Stock Holding History

Citadel Advisors’s Portfolio KRMD Stock Details KRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$93.7K Buy
21,700
+10,000
+85% +$49.6K ﹤0.01% 12066
2025
Q4 		$68K Buy
+11,700
New +$56K ﹤0.01% 11885
2025
Q2 		– Sell
-4,000
Closed -$10.2K – 13906
2025
Q1 		$10.2K Buy
4,000
+1,000
+33% +$3.72K ﹤0.01% 13553
2024
Q4 		$11.6K Hold
3,000
– – ﹤0.01% 13545
2024
Q3 		$8.19K Buy
+3,000
New +$7.4K ﹤0.01% 13319
2024
Q2 		– Sell
-1,000
Closed -$2.36K – 14916
2024
Q1 		$2.36K Buy
1,000
+900
+900% +$1.93K ﹤0.01% 14011
2023
Q4 		$246 Sell
100
-2,400
-96% -$5.72K ﹤0.01% 14076
2023
Q3 		$6.75K Sell
2,500
-1,900
-43% -$5.2K ﹤0.01% 13301
2023
Q2 		$15.2K Buy
4,400
+2,200
+100% +$8.64K ﹤0.01% 12962
2023
Q1 		$9.28K Sell
2,200
-1,200
-35% -$4.72K ﹤0.01% 13593
2022
Q4 		$12.1K Buy
+3,400
New +$9.37K ﹤0.01% 13524
2021
Q2 		– Sell
-40,400
Closed -$142K – 14060
2021
Q1 		$142K Buy
40,400
+29,700
+278% +$129K ﹤0.01% 12114
2020
Q4 		$64K Buy
+10,700
New +$59.9K ﹤0.01% 10468

Other funds holding KRMD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SC
Simcoe Capital Spokane, Washington $109M AUM
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
EFMC
Empire Financial Management Company New York $442M AUM 24.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Citadel Advisors's KRMD Position: Q1 2026 in Review

Citadel Advisors increased its KORU Medical Systems (KRMD) stake by 27% in Q1 2026, buying an estimated $51.6K and bringing the position to 48,726 shares worth $210K. The position accounts for ﹤0.01% of the portfolio, ranked #11316.

Citadel Advisors first reported a position in KRMD in Q3 2020 and has held it in 19 quarters since. The position peaked at $464K in Q4 2020. 91 funds tracked by Wall St. Rank hold KRMD as of Q1 2026.

  • Citadel Advisors held 48,726 shares of KORU Medical Systems worth $210K as of Q1 2026.
  • Citadel Advisors bought 10,413 KORU Medical Systems shares in Q1 2026, an estimated $51.6K.
  • KORU Medical Systems made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #11316 holding.
  • Citadel Advisors first reported a position in KORU Medical Systems in Q3 2020 and has held it in 19 quarters since.
  • Citadel Advisors's KORU Medical Systems position peaked at $464K in Q4 2020.
  • 91 funds tracked by Wall St. Rank held KORU Medical Systems as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.